Fed. Circ. Questions Medical Training Co.'s $100M Deal Theory
A medical training startup urged the Federal Circuit on Friday to revive claims accusing Galderma of a "classic catch-and-kill strategy" to derail what it says could have been a $100 million...To view the full article, register now.
Already a subscriber? Click here to view full article